Showing results (1-10 of 40) with videos related to
Sort By:
Pageof 4
Expert Review of Clinical Pharmacology|April 12, 2018
PD-1/PD-L1 pathway inhibitors in advanced prostate cancerPedro Isaacsson Velho, Emmanuel S AntonarakisExpert Opinion on Investigational Drugs|August 18, 2018
Investigational therapies targeting the androgen signaling axis and the androgen receptor and in prostate cancer - recent developments and future directionsPedro Isaacsson Velho, Michael A CarducciClinical Advances in Hematology & Oncology : H&O|May 14, 2021
New approaches to targeting the androgen receptor pathway in prostate cancerPedro Isaacsson Velho, Diogo Assed Bastos, Emmanuel S AntonarakisThe Prostate|May 6, 2021
Genomic profiles and clinical outcomes in primary versus secondary metastatic hormone-sensitive prostate cancerEmily Nizialek, Su Jin Lim, Hao Wang, et al.The Prostate|November 16, 2021
Clinical and genomic features of SPOP-mutant prostate cancerMari Nakazawa, Mike Fang, Catherine H Marshall, et al.Expert Opinion on Drug Discovery|October 2, 2020
The development of apalutamide for the treatment of prostate cancerPedro Isaacsson Velho, Pedro Tofani Sant' Anna, Rommel Fabricio Pereira da Silva, et al.European Urology|October 20, 2018
Clinical Features and Therapeutic Outcomes in Men with Advanced Prostate Cancer and DNA Mismatch Repair Gene MutationsEmmanuel S Antonarakis, Farah Shaukat, Pedro Isaacsson Velho, et al.The Prostate|January 26, 2018
Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA-repair gene mutations in prostate cancerPedro Isaacsson Velho, John L Silberstein, Mark C Markowski, et al.Biomedicines|July 29, 2023
Bipolar Androgen Therapy: When Excess Fuel Extinguishes the FireNima Nabavi, Seied Rabi Mahdavi, Mohammad Afshar Ardalan, et al.The Prostate|August 8, 2019
Genomic and clinical characterization of pulmonary-only metastatic prostate cancer: A unique molecular subtypeEugene Shenderov, Pedro Isaacsson Velho, Anas H Awan, et al.Pageof 4